Back to search

McMaster University

A DNAzyme Activated by the Bacterial Pathogen Clostridioides difficile

Abstract

dc:description.abstract

Clostridioides difficile infection (CDI) remains a major clinical and public health challenge, necessitating diagnostic approaches that are both rapid and reliable in clinically relevant sample matrices. However, many existing diagnostic methods involve complex workflows and face limitations in robustness, cost, and practical implementation. In this thesis, RNA-cleaving fluorogenic DNAzymes are investigated as molecular recognition elements for CDI diagnostics. A highly active RNA-cleaving fluorogenic DNAzyme, RFD-CD3, is discovered and systematically optimized through truncation and conversion to trans-acting formats. RFD-CD3 exhibits robust catalytic activity under alkaline conditions and was initially identified for the selective detection of Clostridioides difficile. Unexpectedly, subsequent characterization revealed that it is also activated by Listeria monocytogenes, expanding the potential of RNA-cleaving DNAzymes for bacterial diagnostics. To enable application in stool, a heparin-based stabilization strategy combined with alkaline buffer conditions is developed, preserving DNAzyme stability and catalytic activity across pooled and individual stool samples. The optimized and stabilized DNAzyme is subsequently integrated into a DNAzyme-based electrochemical lab-in-a-tube platform, enabling sensitive and selective detection of C. difficile in clinical stool samples. Finally, complementary bioinformatic, proteomic, and biochemical approaches identify RNA polymerase β′ as the protein most strongly associated with RFD-CD3 activation, while suggesting that additional cellular component(s) are required for complete DNAzyme activation. Collectively, this work advances DNAzyme-based diagnostic strategies through DNAzyme discovery and optimization, stabilization in complex biological matrices, translation into electrochemical sensing platforms, and mechanistic investigation of DNAzyme activation, providing a foundation for the development of robust diagnostic technologies suitable for clinical and point-of-care applications.

Degree

thesis:*
Department dc:contributor.department
Biochemistry and Biomedical Sciences
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lee, Soyeon
Advisor dc:contributor.advisor
  • Li, Yingfu

Subjects

dc:subject × 7

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
McMaster University
Base URL
macsphere.mcmaster.ca/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Lee, Soyeon. A DNAzyme Activated by the Bacterial Pathogen Clostridioides difficile. 2026. https://hdl.handle.net/11375/33557